DBV Technologies S.A. (DBV.PA)

EUR 1.29

(-2.58%)

Revenue Summary of DBV Technologies S.A.

  • DBV Technologies S.A.'s latest annual revenue in 2023 was - EUR , down -100.0% from previous year.
  • DBV Technologies S.A.'s latest quarterly revenue in 2024 Q2 was 1.16 Million USD , down -17.48% from previous quarter.
  • DBV Technologies S.A. reported a annual revenue of 4.8 Million USD in annual revenue 2022, down -15.91% from previous year.
  • DBV Technologies S.A. reported a annual revenue of 5.7 Million USD in annual revenue 2021, down 0.0% from previous year.
  • DBV Technologies S.A. reported a quarterly revenue of 1.16 Million USD for 2024 Q2, down -17.48% from previous quarter.
  • DBV Technologies S.A. reported a quarterly revenue of 2.19 Million USD for 2023 Q1, up 268.25% from previous quarter.

Annual Revenue Chart of DBV Technologies S.A. (2023 - 2011)

Historical Annual Revenue of DBV Technologies S.A. (2023 - 2011)

Year Revenue Revenue Growth
2023 - EUR -100.0%
2022 4.8 Million USD -15.91%
2021 5.7 Million USD 0.0%
2020 - EUR 0.0%
2019 - EUR 0.0%
2018 - EUR 0.0%
2017 - EUR 0.0%
2016 - EUR -100.0%
2015 220.84 Thousand EUR -13.83%
2014 256.28 Thousand EUR 2.09%
2013 251.04 Thousand EUR 8.87%
2012 230.59 Thousand EUR 41.14%
2011 163.37 Thousand EUR 0.0%

Peer Revenue Comparison of DBV Technologies S.A.

Name Revenue Revenue Difference
ABIONYX Pharma SA 4.64 Million EUR 100.0%
ABIVAX Société Anonyme 4.62 Million EUR 100.0%
Adocia SA 2.15 Million EUR 100.0%
Aelis Farma SA 9.05 Million EUR 100.0%
Biophytis S.A. - EUR NaN%
Advicenne S.A. 3.15 Million EUR 100.0%
genOway Société anonyme 20.04 Million EUR 100.0%
IntegraGen SA 12.53 Million EUR 100.0%
Medesis Pharma S.A. 300.03 Thousand EUR 100.0%
Neovacs S.A. 533.41 Thousand EUR 100.0%
NFL Biosciences SA - EUR NaN%
Plant Advanced Technologies SA 1.68 Million EUR 100.0%
Quantum Genomics Société Anonyme 19.79 Thousand EUR 100.0%
Sensorion SA 4.74 Million EUR 100.0%
Theranexus Société Anonyme 296.33 Thousand EUR 100.0%
TME Pharma N.V. 17 Thousand EUR 100.0%
Valbiotis SA 4.73 Million EUR 100.0%
TheraVet SA 1.07 Million EUR 100.0%
Valerio Therapeutics Société anonyme 1.8 Million EUR 100.0%
Genfit S.A. 28.56 Million EUR 100.0%
GeNeuro SA - EUR NaN%
Innate Pharma S.A. 51.9 Million EUR 100.0%
Inventiva S.A. 17.47 Million EUR 100.0%
MaaT Pharma SA 2.22 Million EUR 100.0%
MedinCell S.A. 9.16 Million EUR 100.0%
Nanobiotix S.A. 30.05 Million EUR 100.0%
OSE Immunotherapeutics SA 2.22 Million EUR 100.0%
Poxel S.A. 1.98 Million EUR 100.0%
GenSight Biologics S.A. 1.26 Million EUR 100.0%
Transgene SA 1.18 Million EUR 100.0%
Valneva SE 153.71 Million EUR 100.0%